Semaglutide is a GLP-1 receptor agonist
According to FDA-approved prescribing information for semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound), food intake does not significantly affect the absorption or efficacy of these subcutaneous injections
The Food and Drug Administration (FDA) has approved Eli Lillys Foundayo (orforglipron), a once-daily oral glucagon-like peptide-1 (GLP-1) receptor agonist, which offers a noninjectable option for weight management
Can microbiome optimization replace GLP-1 medication
Dont panic, dont double-dose and get guidance if youre uncertain
Of the 14 in the GLP-1RA group, 1 individual was lost to follow up, and 3 were not invited based on being excluded for having gastric bypass surgery (Supplementary Fig